Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. million per patient, payers pushed back. With a record-setting price of $2.1

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Infuse Medical

SEPTEMBER 17, 2020

Sales reps are usually at the forefront of this pressure and have to work hard to make sure the product’s value is understood while adhering to the FDA regulations. As they share content, they receive actionable analytics so they know how to tailor their follow up conversation with each prospect. Web Conferencing Tool.

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Medical Pharmaceutical 52

Pharmaceutical Technology

JUNE 30, 2022

A key challenge in the development of treatments for such indications is the fact that these indications are neglected and often affect populations in lower-income countries, says Dr David Mabey an infectious disease physician at the London School of Hygiene & Tropical Medicine. For example, Merck & Co.

Leads 64

Leads Pharma Medicine FDA 64

Evolve Your Success

JUNE 28, 2022

Despite the very incredible data showing, endoscopic was better for the patient. We got a couple of our products FDA cleared and we raised our first venture financing. We give them this very quantitative assessment of their idea based on market size, the clinical need, and the attractiveness as a physician call point.

Sales 52

Sales Pharma Medical sales reps Medical sales 52

PM360

AUGUST 26, 2024

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. By sequencing the genomes of over 1,000 patients, they have identified 20 new ultra-rare genetic conditions. All diseases are now “rare diseases”. Let’s take cancer for example.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Legacy MEDSearch

JULY 19, 2023

VAPOR 2 is a prospective, multicenter, single-arm study that will treat 235 patients with intermediate-risk, localized prostate cancer at up to 30 U.S. “I am excited to be participating in the VAPOR 2 study and it is a great privilege to treat the first patient,” said Dr. Kella. Francis Medical, Inc., clinical sites.

Medical 52

Medical Side effects Patients Recruitment 52

Rep-Lite

MARCH 14, 2024

Medical sales offer a compelling opportunity for individuals seeking involvement in healthcare innovation, with lucrative financial rewards and a chance to directly impact patient care. This also requires medical sales representatives to be familiar with clinical data based on research and FDA regulations to ensure compliance.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

Legacy MEDSearch

MARCH 30, 2023

The results demonstrated that the LimFlow System achieved 66% amputation-free survival (patients were alive and amputation-free) at six months. This exceeded the FDA’s Performance Goal with statistical significance. The multi-center, prospective, single-arm study encompassed 105 no-option CLTI patients treated at 20 U.S.

Patients 52

Patients Recruitment Medicine Medical 52

Legacy MEDSearch

MAY 1, 2023

OASIS, a 151-patient prospective, multicenter, single-arm, open-label clinical study, was designed to demonstrate the safety and efficacy of BlueWind Medical’s implantable tibial neuromodulation system in reducing symptoms of urgency urinary incontinence (UUI), including urinary urgency and urinary frequency.

Patients 52

Patients Medical Safety Recruitment 52

Clarivate

OCTOBER 7, 2021

Clarivate oncology experts share major takeaways from ESMO and their expected impact on the treatment landscape and patients. Introduced earlier in the treatment paradigm, Keytruda could substantially reduce risk of recurrence in high-risk early-stage melanoma patients. Context: In August 2021, Merck & Co. in the placebo group.

Patients 91

Patients Safety Marketing Physicians 91

Legacy MEDSearch

NOVEMBER 10, 2022

announced consistent and significant blood pressure (“BP”) lowering results across a range of patients with uncontrolled hypertension, including across differences in age, sex, baseline blood pressure, medication level and ethnicity. (“ReCor”) and its parent company, Otsuka Medical Devices Co., mmHg (p<0.0001), favoring uRDN.

Medical 94

Medical Recruitment Patients Management 94

Evolve Your Success

APRIL 11, 2023

About 1% of all patient visits going into an emergency department are due to abscesses. You can imagine that’s not a pleasant thing for patients to experience. My partner is an emergency medicine physician. There’s less patient pain and ultimately less cost for the healthcare facility. It treats abscesses.

Sales 52

Sales Medical Media Medical sales 52

Evolve Your Success

NOVEMBER 1, 2022

In this first installment of this two-part series, Dr. Kupferman shares his take on the importance of medical sales reps to private practice physicians. Again, it’s revolutionizing the way medicine is practiced, and it’s a game-changer for private practice physicians and other physicians alike.

Medical 52

Medical Medical sales reps Doctors Medical sales 52

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. At the same time, Cross says that this is not up to clinicians or the patients, but the payers. Product variation creates patient uncertainty. Citrate could also make these products unsatisfactory to the patients, says Cross.

Marketing 104

Marketing Physicians Competition Patients 104

World of DTC Marketing

NOVEMBER 6, 2020

A quarter million Americans are dead, and hundreds of thousands more are likely to die, because he prioritized his own reelection prospects over saving American lives. Although the FDA is likely to approve the product, several physicians found a quick call that they are highly skeptical, especially if the drug is priced high.

Pharma 153

Pharma Insurance FDA Prospecting 153